Skip to main content

New Job, Same Blog

Three months ago I had the great fortune of being hired for a job that gives me a front-row seat to the world of biomedical technology commercialization. I now work as a Licensing Associate at UT Southwestern Medical Center's Office for Technology Development. UT Southwestern is one of Texas's premier biomedical research institutions, boasting five Nobel laureates (one now emeritus), 19 members of the National Academy of Sciences, and 12 Howard Hughes Medical Institute investigators. The Office for Technology Development manages the institution's efforts in commercializing new technologies developed by its researchers. As Licensing Associate I will be responsible for negotiating and drafting license agreements that grant external entities such as biotech, pharmaceutical, and research reagent companies the right to use and commercialize UT Southwestern-developed technologies. 

Will the nature of my blog change as a result of my new job? Not really. Much of the information I encounter day-to-day in my new job is privileged, so I'm not in a position to blog freely about particular deals I and my office are, were, or will be, involved in. I plan to keep concentrating my blogging efforts on extracting insights about the Texas biomedical industry from publicly available sources of data, with occasional posts highlighting individual people and organizations relevant to my blog's topic. That said, I hope that the blog will come to reflect the ever-increasing understanding of the technology commercialization process I hope I will gain as time progresses.


– Isamu Hartman, PhD







Comments

Post a Comment

Popular posts from this blog

Developing Software: What Should Academic Researchers Keep in Mind? (Part 2)

In Part 1   of this essay, I discussed three learning points I'd gained from my encounters with faculty-developed software in my work as a technology transfer officer at an academic medical research institution. Those points were as follows:  Patents aren't a necessary prerequisite for commercializing software Be deliberate in your use of third-party code If you are going to release your source code publicly, consider doing it under a restrictive open source license When I finished writing it, I knew I had more to say on the topic. You can read Part 1 here . Below is my continuation. 4 - Figuring out the ‘thing’ that’s going to be licensed An important part of handing off a software-based technology from university to private industry is to first figure out exactly what is being handed off. This can be tricky! I’ve discovered that software, as a commercial asset, can take many forms. The licensing professional can bring a lot of clarity to the negotiations by making sure both ...
1 comment
Read more

Medical Device Companies in Texas - Breakdown by City

In a previous post  I described  the geographic distribution of pharmaceutical companies within Texas. I went back to the same   directory of Texas-based pharmaceutical and medical device companies  [see disclaimer below, *] and,  this time,  took a  look at the geographic distribution of companies working in medical devices. The list [see technical note below, **] contains a total of 171 medical device companies - almost twice the number of pharmaceutical companies listed. Here is how they are geographically distributed:  The number in each wedge = the number of medical device companies in that city. "Other" consists of  Bryan/College Station (4 companies),  Athens (3),  Corpus Christi (2),  El Paso (2),  Amarillo (1),  Beaumont/Port Arthur (1),  Longview  (1),  Lubbock  (1),  Midland (1),  Mineral Wells  (1), and  Waco  (1). As with pharmaceutical companies...
4 comments
Read more

Texas-Based Pharmaceutical Companies - Breakdown by City

[Monday, 18 March 2013:  I just noticed that the  directory  I discuss in this post contains the  following disclaimer : "The company listings in this directory are provided as a broad, representative sample of Texas companies in three major areas of the biotechnology industry. This directory is not a comprehensive source of all biotechnology or health-related companies in the state. Due to space limitations, the Office of the Governor Economic Development and Tourism division is unable to include all relevant firms in this document." Thus, whatever interpretations I make based on it should be  considered a rough estimation at best.  -IH] I've written a synopsis of the  2012 Texas Biotechnology Industry Report  (see previous post), but I'm going to hold off on posting it here until it first comes out on the next issue of the Postdoc Informer, the UT Southwestern postdoctoral community's bimonthly newsletter. In the meant...
Post a Comment
Read more